These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
540 related articles for article (PubMed ID: 11038252)
1. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells. Halfter H; Postert C; Friedrich M; Ringelstein EB; Stögbauer F Brain Res Mol Brain Res; 2000 Sep; 80(2):198-206. PubMed ID: 11038252 [TBL] [Abstract][Full Text] [Related]
2. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells. Halfter H; Friedrich M; Postert C; Ringelstein EB; Stögbauer F Mol Cell Biol Res Commun; 1999 May; 1(2):109-16. PubMed ID: 10356359 [TBL] [Abstract][Full Text] [Related]
3. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA. Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477 [TBL] [Abstract][Full Text] [Related]
4. Signaling of type II oncostatin M receptor. Auguste P; Guillet C; Fourcin M; Olivier C; Veziers J; Pouplard-Barthelaix A; Gascan H J Biol Chem; 1997 Jun; 272(25):15760-4. PubMed ID: 9188471 [TBL] [Abstract][Full Text] [Related]
5. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor. Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424 [TBL] [Abstract][Full Text] [Related]
6. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression. Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795 [TBL] [Abstract][Full Text] [Related]
7. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets. Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673 [TBL] [Abstract][Full Text] [Related]
8. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130. Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060 [TBL] [Abstract][Full Text] [Related]
9. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M. Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310 [TBL] [Abstract][Full Text] [Related]
10. Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway. Stancato LF; Sakatsume M; David M; Dent P; Dong F; Petricoin EF; Krolewski JJ; Silvennoinen O; Saharinen P; Pierce J; Marshall CJ; Sturgill T; Finbloom DS; Larner AC Mol Cell Biol; 1997 Jul; 17(7):3833-40. PubMed ID: 9199317 [TBL] [Abstract][Full Text] [Related]
11. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells. Badache A; Hynes NE Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191 [TBL] [Abstract][Full Text] [Related]
12. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy. Podewski EK; Hilfiker-Kleiner D; Hilfiker A; Morawietz H; Lichtenberg A; Wollert KC; Drexler H Circulation; 2003 Feb; 107(6):798-802. PubMed ID: 12591746 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1. Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682 [TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells. Kim H; Hawley TS; Hawley RG; Baumann H Mol Cell Biol; 1998 Mar; 18(3):1525-33. PubMed ID: 9488469 [TBL] [Abstract][Full Text] [Related]
15. Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo? Sriram K; Benkovic SA; Hebert MA; Miller DB; O'Callaghan JP J Biol Chem; 2004 May; 279(19):19936-47. PubMed ID: 14996842 [TBL] [Abstract][Full Text] [Related]
16. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway. Li WQ; Dehnade F; Zafarullah M J Immunol; 2001 Mar; 166(5):3491-8. PubMed ID: 11207308 [TBL] [Abstract][Full Text] [Related]
17. Signaling pathway of ciliary neurotrophic factor in neuroblastoma cell lines. Kuroda H; Sugimoto T; Horii Y; Sawada T Med Pediatr Oncol; 2001 Jan; 36(1):118-21. PubMed ID: 11464862 [TBL] [Abstract][Full Text] [Related]
18. Activation of the JAK-STAT signal transduction pathway by oncostatin-M cultured human and mouse osteoblastic cells. Levy JB; Schindler C; Raz R; Levy DE; Baron R; Horowitz MC Endocrinology; 1996 Apr; 137(4):1159-65. PubMed ID: 8625884 [TBL] [Abstract][Full Text] [Related]
19. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade. Ogata A; Chauhan D; Teoh G; Treon SP; Urashima M; Schlossman RL; Anderson KC J Immunol; 1997 Sep; 159(5):2212-21. PubMed ID: 9278309 [TBL] [Abstract][Full Text] [Related]
20. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a. Piekorz RP; Hocke GM Cytokine; 1997 Sep; 9(9):639-49. PubMed ID: 9325012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]